Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride Sterile Suspension

요약

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Pharmacia & Upjohn Co. One supplemental NADA provides for veterinary prescription use of ceftiofur hydrochloride sterile suspension for intramuscular or subcutaneous injection in cattle for treatment of bovine respiratory disease and acute bovine interdigital necrobacillosis. The second supplemental NADA provides for a revised label warning against use in veal calves.